help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bar, R. S.
Right arrow Articles by Booth, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bar, R. S.
Right arrow Articles by Booth, B. A.

Endocrinology, Vol 127, 3243-3245, Copyright © 1990 by Endocrine Society


ARTICLES

Tissue localization of perfused endothelial cell IGF binding protein is markedly altered by association with IGF-I

RS Bar, M Boes, BL Dake, A Sandra, M Bayne, M Cascieri and BA Booth
V.A. Hospital, Iowa City, Iowa.

Perfused endothelial cell IGF binding proteins (ECBP) have been previously demonstrated to leave the microcirculation of the rat heart and distribute primarily in connective tissue elements of the heart. In the present study, ECBP have been crosslinked to IGF-I and the biologically inactive [1-27,gly4,38-70]-hlGF-I, an analog of IGF-I lacking the type I IGF receptor domain. The crosslinked ECBPs were perfused through the isolated rat heart and their tissue distributions determined. Both [ECBP-Analog] and [ECBP-IGF-I] left the microcirculation of the heart. [ECBP-Analog] preferentially localized in connective tissue elements with a muscle:connective tissue ratio of approximately 1:6, similar to the tissue distribution of perfused ECBP. In contrast, the [ECBP-IGF-I] complexes localized in cardiac muscle with a muscle to connective tissue ratio of approximately 3:1, virtually identical to the tissue distribution of IGF-I when the IGF-I is perfused through the heart in the absence of any binding proteins. We conclude that 1) ECBP in the presence of IGF will cross capillary boundaries and 2) the tissue distribution of [ECBP-IGF-I] is dictated by the IGF-I molecule.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
L. D. Payet, S. M. Firth, and R. C. Baxter
The Role of the Acid-Labile Subunit in Regulating Insulin-Like Growth Factor Transport across Human Umbilical Vein Endothelial Cell Monolayers
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. L. Knudtson, M. Boes, A. Sandra, B. L. Dake, B. A. Booth, and R. S. Bar
Distribution of Chimeric IGF Binding Protein (IGFBP)-3 and IGFBP-4 in the Rat Heart: Importance of C-Terminal Basic Region
Endocrinology, September 1, 2001; 142(9): 3749 - 3755.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Bang, J. Nygren, C. Carlsson-Skwirut, A. Thorell, and O. Ljungqvist
Postoperative Induction of Insulin-Like Growth Factor Binding Protein-3 Proteolytic Activity: Relation to Insulin and Insulin Sensitivity
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2509 - 2515.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
R. A. Hill and J. M. Pell
Regulation of Insulin-Like Growth Factor I (IGF-I) Bioactivity in Vivo: Further Characterization of an IGF-I-Enhancing Antibody
Endocrinology, March 1, 1998; 139(3): 1278 - 1287.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society